Pfizer and BioNTech have begun a clinical trial for their omicron-specific coronavirus vaccine, the companies announced Tuesday, as vaccine makers scramble to reformulate shots to target the infectious variant. The study will evaluate the vaccine for safety, tolerability and strength of immune response in up to 1,420 healthy adults ages 18 to 55, the companies said in a statement.
The companies will test the vaccine in unvaccinated people as part of a three-shot course, as a booster shot in those who have received two Pfizer-BioNTech doses already and as a fourth dose for people who have already had three Pfizer-BioNTech shots.
meaning they’re available nationally
Hi, I am a structural engineer from Iran who have many ideas. I have summarized some of my ideas on my twitter(I suggest look at the idea of generating electricity by gravity). I want to work with companies and investors. Do you want to cooperate?
Keep it! The virus ran it course already. Enough is enough!
Big pharma just raking in the dough, thanks corrupt politicians world wide.
What now? One shot for every variant? Guinea pig conspiracy I choose you.
You guys, it’s literally the cold.
For every variant u must take a shot 😅🤣😂😹
From go on last letter greek Alpfabet
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.